Epithelial-to-mesenchymal transition in the development of adenomyosis
article
OA: diamond
CC0
⤵ 6 in-corpus citations
AI-generated summary
This article reviews evidence that estrogen-induced epithelial-to-mesenchymal transition plays a role in the pathogenesis of adenomyosis, a hormone-related gynecological disorder.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Adenomyosis is a hormone-related disease that affects 10–66% of women, and women with this disorder suffer from menorrhagia, dysmenorrhea, pelvic pain, abnormal uterine bleeding, and/or infertility. Regarding the etiology of the disease, the current trend of thought is that adenomyosis or adenomyoma results as a down-growth and invagination of the endometrial basalis into the adjacent myometrium after disruption of the normally intact boundary between the two. The eutopic endometrium of adenomyosis presents invasive characteristics, including increased angiogenesis and proliferation, decreased apoptosis, induction of the local production of estrogens, induction of progesterone resistance, and impaired cytokine expression, and these changes enhance the ability of the endometrium to infiltrate the junctional zone myometrium and the growth of ectopic tissue. Hysterectomy is the major strategy to relieve secondary dysmenorrhea caused by adenomyosis. However, fertility and uterine preservation are compromised by such treatment. The traditional pharmacological therapies for adenomyosis are primarily aimed at the suppression of endogenous estrogen production, but the results are not satisfactory. Thus, there is an urgent need to develop novel treatment strategies for adenomyosis. There has been evidence that indicates that the estrogen-induced epithelial–mesenchymal transition (EMT) may play a role in the development of adenomyosis. In this article, we will concentrate on the estrogen-induced EMT in the pathogenesis of adenomyosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (79)
- Adenomyosis—A Result of Disordered Stromal Differentiation via openalex
- Adenomyosis: epidemiological factors via openalex
- Adenomyosis: New Knowledge is Generating New Treatment Strategies via openalex
- Adenomyosis uteri via openalex
- A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis via openalex
- Clinical usefulness of determination of estradiol level in the menstrual blood for patients with endometriosis. via openalex
- Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Endometriosis: The Ultimate Hormonal Disease via openalex
- Enhanced invasion of stromal cells from adenomyosis in a three-dimensional coculture model is augmented by the presence of myocytes from affected uteri via openalex
- Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis via openalex
- Estrogen biosynthesis in human uterine adenomyosis via openalex
- Estrogen receptors and human disease: an update via openalex
- Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Fibromuscular differentiation in deeply infiltrating endometriosis is a reaction of resident fibroblasts to the presence of ectopic endometrium via openalex
- History of adenomyosis via openalex
- Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via openalex
- Immunohistologic localization of estrone sulfatase in uterine endometrium and adenomyosis via openalex
- Immunohistologic Localization of Estrone Sulfatase in Uterine Endometrium and Adenomyosis via openalex
- Increased activation of nuclear factor-kappa B (NF-κB) in isolated peritoneal macrophages of patients with endometriosis via openalex
- <i>β</i> ‐Catenin activation contributes to the pathogenesis of adenomyosis through epithelial–mesenchymal transition via openalex
- Keep the pressure on for more transparency of clinical trials on endometriosis via openalex
- Molecular characterization of human adenomyosis via openalex
- Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. via openalex
- Oestrogen‐induced angiogenesis promotes adenomyosis by activating the <scp>S</scp>lug‐<scp>VEGF</scp> axis in endometrial epithelial cells via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Pathophysiology of adenomyosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Phenotypic Characterisation of the Inner and Outer Myometrium in Normal and Adenomyotic Uteri via openalex
- Possible roles of oxytocin receptor and vasopressin-1α receptor in the pathomechanism of dysperistalsis and dysmenorrhea in patients with adenomyosis uteri via openalex
- Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis via openalex
- Reduced proliferation and cell adhesion in endometriosis via openalex
- Role of Estrogen Receptor-β in Endometriosis via openalex
- Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17β-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism via openalex
- The elusive adenomyosis of the uterus—revisited via openalex
- The endometrial–myometrial junction: a fresh look at a busy crossing via openalex
- The Endometrium in Adenomyosis via openalex
- The pathophysiology of endometriosis and adenomyosis: tissue injury and repair via openalex
- The pathophysiology of uterine adenomyosis: an update via openalex
- Uterine junctional zone: function and disease via openalex
- W6683844666 via openalex
- W1964081206 via openalex
- W1989012283 via openalex
- W1992297132 via openalex
- W2006356335 via openalex
- W2007283484 via openalex
- W2012551574 via openalex
- W2025647419 via openalex
- W2029915978 via openalex
- W2034864360 via openalex
- W2042198997 via openalex
- W2047249984 via openalex
- W2056479931 via openalex
- W2057085814 via openalex
- W2063011414 via openalex
- W2063581615 via openalex
- W2070585859 via openalex
- W2076583198 via openalex
- W2089708673 via openalex
- W2092174240 via openalex
- W2092843143 via openalex
- W2104698937 via openalex
- W2105724560 via openalex
- W2112680319 via openalex
- W2114428497 via openalex
- W2115792588 via openalex
- W2119557647 via openalex
- W2121306814 via openalex
- W2125053924 via openalex
- W2133799748 via openalex
- W2143468862 via openalex
- W2152628855 via openalex
- W2171875732 via openalex
- W2279547604 via openalex
- W6605286029 via openalex
- W6609642172 via openalex
- W6650631905 via openalex
- W6669912067 via openalex
Cited by (6)
- Knockdown of miR-150-5p reduces hypoxia-induced autophagy and epithelial-mesenchymal transition of endometriotic cells via regulating the PDCD4/NF-κB signaling pathway 2022
- Immune cells and Notch1 signaling appear to drive the epithelial to mesenchymal transition in the development of adenomyosis in mice 2021
- Physiopathologie de l’adénomyose : une énigme non résolue 2021
- The effects of isoliquiritigenin on endometriosis in vivo and in vitro study 2020
- A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis 2019
- Decreased Endometrial Expression of Leukemia Inhibitory Factor Receptor Disrupts the STAT3 Signaling in Adenomyosis During the Implantation Window 2016
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK